GLP-1 receptor agonists are injectable treatments for type 2 diabetes and obesity, available in both daily and weekly formulations
Mode of action of taurine as a neuroprotector
A 2025 meta-analysis across 36 randomized controlled trials confirmed that weight regain after stopping GLP-1 receptor agonists is common, drug-dependent, and proportional to the original weight lost meaning the more weight lost on the drug, the more returned after stopping
Nayan Patel , pharmacist, wellness expert, and one of the worlds leading authorities on glutathione, the bodys master antioxidant, to unpack why so many high performers hit a wall despite doing everything right
We specialize in offering as pain free an injection as possible
They acknowledged limitations including the use of age-based menopausal proxies and the 36-month follow-up window, and called for prospective studies with standardized GLP-1 RA exposure definitions and longer observation periods to validate these findings